You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

Guidelines & Advice

About Guidelines Email Guidelines Team

Displaying Guidelines

361 Items

Therapy for Stage IV Non–Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update

Document Status: Current
ID: 7-A-2018-2
Version: N/A

Jan 2020

Thoracic Surgical Oncology Standards

Document Status: Current
ID: 17-1
Version: 2

Mar 2015

Three-Dimensional MR-Guided Intracavitary and Interstitial Brachytherapy for Cervical Cancer

Document Status: Current
ID: GL 21-2v2
Version: 2

Nov 2018

Treatment of Acute Myeloid Leukemia in Older Patients

Document Status: Archived
ID: 6-14

Dec 2008

Treatment of Chronic Myeloid Leukemia with Imatinib

Document Status: Archived
ID: 6-15

Dec 2013

Treatment of Multiple Myeloma: ASCO and CCO Joint Clinical Practice Guideline

Document Status: In-Review
ID: GL 6-A-2018-1

Mar 2019

Treatment with Fludarabine for Patients with Follicular and Other Low Grade Non-Hodgkin's Lymphoma and Waldenstrom's Macroglobulinemia

Document Status: Archived
ID: 6-2
Version: 2

Aug 2013

Use of 5-HT3 Receptor Antagonists in Patients Receiving Moderately or Highly Emetogenic Chemotherapy

Document Status: Archived
ID: 12-3

Jan 2003

Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer

Document Status: Current
ID: GL 1-22-A
Version: 2

Jul 2022

Use of Adjuvant Chemotherapy Following Cystectomy in Patients with Deep Muscle-Invasive Transitional Cell Carcinoma of the Bladder

Document Status: Archived
ID: 3-2-1

Oct 2012

Use of Amifostine to Ameliorate the Toxic Effects of Chemotherapy in the Treatment of Cancer

Document Status: Archived
ID: 12-6

May 2012

Use of Chemotherapy in Advanced Unresectable or Metastatic Transitional Cell Carcinoma of the Bladder or Urothelium

Document Status: Archived
ID: 3-12

Nov 2011